Core Viewpoint - Ningbo Suobao Protein Technology Co., Ltd. reported a significant increase in revenue and net profit for the first three quarters of 2025, indicating strong growth in the soybean protein market driven by rising consumer demand for health and safety in food products [1][2]. Group 1: Financial Performance - The company achieved operating revenue of 1.24 billion yuan, a year-on-year increase of 7.37% [1] - Net profit attributable to shareholders reached 147 million yuan, reflecting a substantial year-on-year growth of 60.00% [1] - In Q3 alone, operating revenue was 466 million yuan, up 21.75% year-on-year, while net profit for the quarter was 49.26 million yuan, marking a remarkable increase of 135.87% [1] Group 2: Business Operations - Suobao Protein specializes in the research, production, and sales of non-GMO soybean protein products, having established a comprehensive deep processing industry chain for non-GMO soybeans [1] - The main products include soybean isolate protein, soybean concentrate protein, textured protein, soybean dietary fiber, and non-GMO soybean oil [1] - The company is actively expanding its international market presence while consolidating its domestic market, enhancing brand recognition and influence [2] Group 3: Industry Trends - There is a growing consumer focus on environmental and health issues, leading to increased demand for organic, green, functional, and health foods globally [1] - Soybean protein is widely used in various sectors, including plant-based meat, meat products, snacks, health products, nutritional supplements, pet food, and bio-fermentation, indicating a broad market development potential [1]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上海证券交易所上市公司自律监管指引第 3 号行业信息披露：第十四 号——食品制造》的相关要求，山东嘉华生物科技股份有限公司（以下简称"公 司"）现将 2025 年前三季度主要经营数据公告如下： | 项目 | 金额 | 比例（%） | | --- | --- | --- | | 大豆蛋白 | 60,916.36 | 59.48 | | 大豆油 | 22,652.71 | 22.12 | | 大豆膳食纤维 | 6,348.44 | 6.20 | | 低温食用豆粕 | 2,987.91 | 2.92 | | 蒸汽 | 3,941.48 | 3.85 | | 电力 | 2,495.07 | 2.43 | | 副产品 | 3,071.29 | 3.00 | | 合计 | 102,413.26 | 100.00 | 一、按产品类别分类的销售情况 单位：万元 证券代码：603182 证券简称：嘉华股份 公告编号：2025-030 山东嘉华生物科技股份有限公司 2025 年前三季度主要经营 ...

Core Viewpoint - Jia Hua Co., Ltd. reported a decline in revenue but an increase in profit for the first half of 2025, indicating a mixed performance in its operations [1][3]. Financial Performance - The company achieved an operating revenue of 681 million yuan, a year-on-year decrease of 12.86% [1]. - The net profit attributable to shareholders was 62 million yuan, reflecting a year-on-year growth of 7.79% [1]. - The net profit margin improved from 7.39% in the first half of 2024 to 9.15% in 2025 [3]. - The gross profit margin increased from 13.20% to 16.00% [3]. - The return on equity was 5.64%, with a year-on-year increase of 0.12 percentage points, indicating overall improvement in profitability quality [3]. Operational Efficiency - The inventory turnover days increased to 71.22 days, up by 11.22% compared to the first half of 2024, suggesting increased pressure on inventory management [5]. - The net cash flow from operating activities was 4 million yuan, a significant decline from 54 million yuan in the same period of 2024 [5]. - The debt-to-asset ratio for the first half of 2025 was 17.89%, a decrease of 5.59 percentage points year-on-year, indicating a lighter debt burden and a more stable financial structure [5]. Institutional Holdings - As of the first half of 2025, the number of institutions holding Jia Hua Co., Ltd. shares decreased to 3, down from 50 in the same period of 2024, showing a significant decline in institutional investor participation [7]. - The company's market capitalization peaked at 4.015 billion yuan on September 19, 2022, while the current market cap stands at 2.370 billion yuan, indicating a need for a 69.44% increase in stock price to reach its historical high [7]. - Despite the decline in institutional interest, the company has shown positive changes in profitability quality and financial structure [7].

证券代码：603182 证券简称：嘉华股份 公告编号：2025-019 山东嘉华生物科技股份有限公司 2025 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上海证券交易所上市公司自律监管指引第 3 号行业信息披露：第十四 号——食品制造》的相关要求，山东嘉华生物科技股份有限公司（以下简称"公 司"）现将 2025 年半年度主要经营数据公告如下： | | | 单位：万元 | | --- | --- | --- | | 项目 | 金额 | 比例（%） | | 大豆蛋白 | 39,554.66 | 58.23 | | 大豆油 | 14,944.04 | 22.00 | | 大豆膳食纤维 | 4,158.90 | 6.12 | | 低温食用豆粕 | 2,426.80 | 3.57 | | 蒸汽 | 3,115.44 | 4.59 | | 电力 | 1,666.80 | 2.45 | | 副产品 | 2,067.26 | 3.04 | | 合计 | 67,933.90 | 100.00 | 一、按产品 ...

证券代码：603182 证券简称：嘉华股份 公告编号：2025-013 山东嘉华生物科技股份有限公司 2025 年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上海证券交易所上市公司自律监管指引第 3 号行业信息披露：第十四 号——食品制造》的相关要求，山东嘉华生物科技股份有限公司（以下简称"公 司"）现将 2025 年第一季度主要经营数据公告如下： | 项目 | 金额 | 比例（%） | | --- | --- | --- | | 大豆蛋白 | 19,867.28 | 57.33 | | 大豆油 | 7,158.68 | 20.66 | | 大豆膳食纤维 | 2,404.70 | 6.94 | | 低温食用豆粕 | 1,293.57 | 3.73 | | 蒸汽 | 2,022.53 | 5.84 | | 电力 | 847.35 | 2.45 | | 副产品 | 1,059.51 | 3.05 | | 合计 | 34,653.62 | 100.00 | 一、按产品类别分类的销售情况 单位：万元 ...